Weifa ASA announced the launch of Zonat(R) tablets, which is indicated for short-term symptomatic treatment of occasional insomnia in adults over 18 years old. Zonat(R) contains the antihistamine doxylamine, which is well established as a non-prescription (OTC) product for occasional insomnia in several European countries. In Norway Zonat(R) will require medical prescription.